Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Isatuximab SAR650984 for Autoimmune Hemolytic Anemia
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial is testing a new drug, isatuximab, for people with wAIHA (warm autoimmune hemolytic anemia). The primary objectives are to evaluate the safety and tolerability of isatuximab and the efficacy of the selected dose. Secondary objectives include evaluating the durability of response to isatuximab and the impact of isatuximab treatment on fatigue.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.